Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Paul M. Daniel"'
Autor:
Paul M. Daniel, Frédéric Hollande, Andrew P. Morokoff, Gulay Filiz, Sebastian Dworkin, Theo Mantamadiotis, Daniel Brown, Wayne Ng, Nicole Kountouri, Stephanie Amiridis
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 2, p e0172791 (2017)
PLoS ONE, Vol 12, Iss 2, p e0172791 (2017)
Glioblastoma (GBM) is a heterogeneous tumor of the brain with a poor prognosis due to recurrence and drug resistance following therapy. Genome-wide profiling has revealed the existence of distinct GBM molecular subtypes that respond differently to ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b93541fc9763c8c99c234f613764a359
Autor:
Daniel V Brown, Gulay Filiz, Paul M Daniel, Frédéric Hollande, Sebastian Dworkin, Stephanie Amiridis, Nicole Kountouri, Wayne Ng, Andrew P Morokoff, Theo Mantamadiotis
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0172791 (2017)
Glioblastoma (GBM) is a heterogeneous tumor of the brain with a poor prognosis due to recurrence and drug resistance following therapy. Genome-wide profiling has revealed the existence of distinct GBM molecular subtypes that respond differently to ag
Externí odkaz:
https://doaj.org/article/5a7ac15d4e7045b793592d822cc16281
Autor:
Andrew H. Kaye, Stanley S. Stylli, Gulay Filiz, Paul M. Daniel, Martin James Tymms, Theo Mantamadiotis, Robert G. Ramsay
Publikováno v:
Experimental and molecular pathology. 105(1)
Limitations in discovering useful tumor biomarkers and drug targets is not only due to patient-to-patient differences but also due to intratumor heterogeneity. Heterogeneity arises due to the genetic and epigenetic variation of tumor cells in respons
Autor:
Elizabeth Vincan, Karen G. Montgomery, Paul Waring, Colin W. Pouton, Yi Zhang, Dustin J. Flanagan, Daniel V Brown, Gulay Filiz, John M. Haynes, Terrance Grant Johns, Theo Mantamadiotis, Paul M. Daniel, Wayne A. Phillips, Michael Christie
BACKGROUND: Hyperactivation of phosphoinositide 3-kinase (PI3K) signaling is common in cancers, but the precise role of the pathway in glioma biology remains to be determined. Some understanding of PI3K signaling mechanisms in brain cancer comes from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b28a2a34b083720063fa59e8cefe933
https://europepmc.org/articles/PMC6140786/
https://europepmc.org/articles/PMC6140786/
Autor:
Paul M. Daniel, Stanley S. Stylli, Martin J. Tymms, Theo Mantamadiotis, Robert G. Ramsay, Andrew H. Kaye, Gulay Filiz
Limitations in discovering useful tumor biomarkers and drug targets is not only due to patient-to-patient differences but also due to intratumoral heterogeneity. Heterogeneity arises due to the genetic and epigenetic variation of tumor cells in respo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb7e6ad528bfc9fa6f78836b58125277
Autor:
Yi Zhang, Paul Waring, Terrance Grant Johns, Gulay Filiz, Daniel V Brown, Paul M. Daniel, John M. Haynes, Elizabeth Vincan, Karen G. Montgomery, Theo Mantamadiotis, Michael Christie, Colin W. Pouton, Wayne A. Phillips, Dustin J. Flanagan
Hyperactivation of the PI3K signaling is common in human cancers, including gliomas, but the precise role of the pathway in glioma biology remains to be determined. Some limited understanding of PI3K signaling in brain cancer come from studies on neu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07d2511405c94e1768e17a4a0d55b35f
Publikováno v:
Cell Death & Disease
In some cell types, activation of the second messenger cAMP leads to increased expression of proapoptotic Bim and subsequent cell death. We demonstrate that suppression of the cAMP pathway is a common event across many cancers and that pharmacologica
Autor:
Paul M. Daniel
Publikováno v:
Cancer Research. 78:660-660
Glioblastoma (GBM) is the most commonly diagnosed glioma and has the poorest median survival of all brain tumours at only 14 months. Despite intensive characterisation of this disease through ‘omic' investigations which has led to the identificatio
Autor:
Giovanna M. D'Abaco, Theo Mantamadiotis, Wayne Ng, Andrew P. Morokoff, Andrew J Gogos, Daniel Brown, Paul M. Daniel
Publikováno v:
Oncotarget
Accumulating evidence suggests that the stem cell markers CD133 and CD44 indicate molecular subtype in Glioblastoma Multiforme (GBM). Gene coexpression analysis of The Cancer Genome Atlas GBM dataset was undertaken to compare markers of the Glioblast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eac55ff9765bbe6024a7035cc45c3c0
http://www.impactjournals.com/oncotarget/misc/linkedout.php?pii=3365
http://www.impactjournals.com/oncotarget/misc/linkedout.php?pii=3365
Autor:
Giovanna M. D'Abaco, Nikos Papalexis, Paul M. Daniel, Daniel Brown, Robert G. Ramsay, Frédéric Hollande, Gulay Filiz, Theo Mantamadiotis, Wayne A. Phillips, Jordane Malaterre, Michael Gonzales
Publikováno v:
Oncogenesis
The cyclic-AMP response element binding (CREB) protein has been shown to have a pivotal role in cell survival and cell proliferation. Transgenic rodent models have revealed a role for CREB in higher-order brain functions, such as memory and drug addi